This site was designed with the
.com
website builder. Create your website today.
Start Now

DARREN WOGMAN

Darren Wogman MSc

Get In Touch
  • Home

  • Research Pieces

  • Education

  • Skills

  • Recognitions

  • Privacy

  • More

    Use tab to navigate through the menu items.

    darren@wogman.com

    123-456-7890

    • All Posts
    • 101
    • Industry
    • Preclinical
    • Pharmacology
    • Toxicology
    • Clinical Studies
    • Clinical Development
    • Formulation Science
    • Clinical Pharmacology
    • Statistics and Data
    • Biologic and Advanced Therapies
    • Drug Safety & Ethics
    • Drug Regulatory Affairs
    Search
    Darren Wogman
    • Jul 8, 2021
    • 19 min

    A business case assessment for a novel mAb product

    A business case assessment for a novel mAb product identified for the treatment of severe asthma. Clinical Development and marketability.

    24 views0 comments
    Darren Wogman
    • May 25, 2021
    • 10 min

    Critique of Hamdy FC et al. N Engl J Med 2016; 375:1415-1424

    Critique of Hamdy FC et al. 10-year outcomes after monitoring, surgery or radiotherapy for localised prostate cancer. N Engl J Med 2016; 375

    98 views0 comments
    Darren Wogman
    • May 25, 2021
    • 10 min

    Clinical Trial Dataset Analysis - A phase 2a efficacy, safety and tolerability study

    Clinical Trial Dataset Analysis - A phase 2a efficacy, safety and tolerability study on treating patients with schizophrenia

    23 views0 comments
    Darren Wogman
    • May 1, 2021
    • 13 min

    Using the target product profile write the following strategies and justify the strategy adopted

    Using the target product profile write the following strategies and justify the strategy adopted. Darren Wogman MSc

    96 views0 comments
    Darren Wogman
    • May 1, 2021
    • 24 min

    A target product profile (TPP) for ATL-104. Use in Oral Mucositis (OM). Darren Wogman MSc

    A target product profile (TPP) for ATL-104. Use in Oral Mucositis (OM). Darren Wogman MSc

    144 views0 comments
    Darren Wogman
    • Apr 25, 2021
    • 19 min

    Clinical pharmacology support studies routinely required for IMP registration.

    Clinical pharmacology support studies routinely required for IMP registration. SmPCs, ABA, FDI, ADME, QT, Renal, Hepatic, PopPK, DDI, BE

    229 views0 comments
    Darren Wogman
    • Apr 24, 2021
    • 8 min

    PK/PD Data Analysis - Macrolide Antibiotic

    PK/PD Data Analysis - Macrolide Antibiotic. Original Dataset not included. Appendices not included.

    10 views0 comments
    Darren Wogman
    • Apr 24, 2021
    • 17 min

    The pharmacological evidence required to justify clinical development of a drug candidate

    The pharmacological evidence required to justify clinical development of a drug candidate for depression | Darren Wogman

    71 views0 comments
     

    Subscribe Form

    Thanks for submitting!

    • Facebook
    • Twitter
    • LinkedIn

    ©2021 by Darren Wogman. Proudly created with Wix.com